and
outcome definitions and events were collected and collated.
Risk of bias in RCTs (including blinding of participants,
method of sequence generation and allocation concealment,
intention-to-treat analysis, early trial stopping for efficacy
before the planned enrollment was completed, and
loss to follow-up) was also assessed.